SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insmed Inc. (INSM)
INSM 186.40-1.7%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (53)5/29/2003 8:05:12 PM
From: keokalani'nui  Read Replies (1) of 136
 
Hey George

Did you need to remind me of this? I had a little slug of INSM at an ave. cost of $.45 and sold it for $.58 six weeks and a quadruple ago following my penetrating due diligence. I sold idbe ($10) at $3 a couple months ago too!

<g> <ng>

I assume the asco stuff is BLP3. I haven't seen it, but it is surely pre-clinical and so yes, a long way away; and hard to think of it as an insm asset anyway given dependency on lead program.

BVF is raking it in this quarter.

Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext